US Patent Issued to INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS on Sept. 1 for "Method for preventing or treating cancer by blocking excessive production of phosphorylated vimentin" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,061, issued on Sept. 1, was assigned to INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (Gyeonggi-do, South Korea).

"Method for preventing or treating cancer by blocking excessive production of phosphorylated vimentin" was invented by Hyungshin Yim (Seoul, South Korea) and Hay Ran Jang (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Finding that vimentin is overexpressed in cancer cells and the PLK1-induced phosphorylation of vimentin leads to tumorigenesis and cancer metastasis, the present invention suggests two methods of reducing frequency of interaction between PLK1 and vimentin as a strategy ...